Krystal Biotech KRYS Stock
165.43 USD
{{ price }}
2.092076%
{{change_pct}}%
SECTOR
Healthcare
INDUSTRY
Biotechnology
COUNTRY
United States
Exchange
NasdaqGS
Market Cap
4.95B USD
LOW - HIGH [24H]
171.81
-
179.1 USD
VOLUME [24H]
20.42K USD
{{ volume }}
P/E Ratio
456.89
Earnings per share
0.38 USD
Krystal Biotech Price Chart
Krystal Biotech KRYS Financial and Trading Overview
| Krystal Biotech stock price | 165.43 USD |
| Previous Close | 129.38 USD |
| Open | 129.05 USD |
| Bid | 0 USD x 800 |
| Ask | 0 USD x 800 |
| Day's Range | 124.19 - 129.05 USD |
| 52 Week Range | 51.68 - 131.8 USD |
| Volume | 348.46K USD |
| Avg. Volume | 282.03K USD |
| Market Cap | 3.22B USD |
| Beta (5Y Monthly) | 0.833802 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | 0.38 USD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 135.88 USD |
KRYS Valuation Measures
| Enterprise Value | 2.88B USD |
| Trailing P/E | N/A |
| Forward P/E | -62.984848 |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | N/A |
| Price/Book (mrq) | 6.571293 |
| Enterprise Value/Revenue | N/A |
| Enterprise Value/EBITDA | -22.488 |
Trading Information
Krystal Biotech Stock Price History
| Beta (5Y Monthly) | 0.833802 |
| 52-Week Change | 124.70% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 131.8 USD |
| 52 Week Low | 51.68 USD |
| 50-Day Moving Average | 99.68 USD |
| 200-Day Moving Average | 81.46 USD |
KRYS Share Statistics
| Avg. Volume (3 month) | 282.03K USD |
| Avg. Daily Volume (10-Days) | 312.89K USD |
| Shares Outstanding | 25.8M |
| Float | 18.94M |
| Short Ratio | 3.17 |
| % Held by Insiders | 15.02% |
| % Held by Institutions | 83.10% |
| Shares Short | 1.19M |
| Short % of Float | 5.45% |
| Short % of Shares Outstanding | 4.62% |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2022 |
| Most Recent Quarter (mrq) | March 31, 2023 |
| Next Fiscal Year End | December 31, 2023 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | 0% |
| Gross Margin | 0% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | -14.32% |
| Return on Equity (ttm) | -26.068% |
Income Statement
| Revenue (ttm) | N/A |
| Revenue Per Share (ttm) | N/A |
| Quarterly Revenue Growth (yoy) | N/A |
| Gross Profit (ttm) | N/A |
| EBITDA | -127884000 USD |
| Net Income Avi to Common (ttm) | -135307008 USD |
| Diluted EPS (ttm) | -5.08 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 350.39M USD |
| Total Cash Per Share (mrq) | 13.58 USD |
| Total Debt (mrq) | 8.76M USD |
| Total Debt/Equity (mrq) | 1.79 USD |
| Current Ratio (mrq) | 10.133 |
| Book Value Per Share (mrq) | 18.978 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -111232000 USD |
| Levered Free Cash Flow (ttm) | -109634128 USD |
Profile of Krystal Biotech
| Country | United States |
| State | PA |
| City | Pittsburgh |
| Address | 2100 Wharton Street |
| ZIP | 15203 |
| Phone | 412 586 5830 |
| Website | https://www.krystalbio.com |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | 210 |
Krystal Biotech, Inc., a biotechnology company, develops and commercializes genetic medicines for patients with rare diseases in the United States. It develops beremagene geperpavec (B-VEC) for dystrophic epidermolysis bullosa; KB105 for treating patients with deficient autosomal recessive congenital ichthyosis; KB104 for netherton syndrome; and KB407 for Cystic Fibrosis. The company also develops KB408 for Alpha-1 antitrypsin deficiency; and KB301 for aesthetic skin conditions. Krystal Biotech, Inc. was founded in 2016 and is headquartered in Pittsburgh, Pennsylvania.
Q&A For Krystal Biotech Stock
What is a current KRYS stock price?
Krystal Biotech KRYS stock price today per share is 165.43 USD.
How to purchase Krystal Biotech stock?
You can buy KRYS shares on the NasdaqGS exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Krystal Biotech?
The stock symbol or ticker of Krystal Biotech is KRYS.
Which industry does the Krystal Biotech company belong to?
The Krystal Biotech industry is Biotechnology.
How many shares does Krystal Biotech have in circulation?
The max supply of Krystal Biotech shares is 29.93M.
What is Krystal Biotech Price to Earnings Ratio (PE Ratio)?
Krystal Biotech PE Ratio is 456.89474000 now.
What was Krystal Biotech earnings per share over the trailing 12 months (TTM)?
Krystal Biotech EPS is 0.38 USD over the trailing 12 months.
Which sector does the Krystal Biotech company belong to?
The Krystal Biotech sector is Healthcare.
Krystal Biotech KRYS included in indexes
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume |
|---|
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume | |
|---|---|---|---|---|---|---|---|
| {{ item.name }} {{ item.symbol }} | {{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.components_count }} - | {{ item.volume }} {{ item.volume_usd }} |
| NASDAQ Composite IXIC | 16175.09 USD — |
-1.62
|
3.94B USD — | 16125.33 USD — | 16341.46 USD — | — - | 3.94B USD — |
| NASDAQ Global Market Composite NQGM | 2160.36 USD — |
-2.45
|
— — | 2147.48 USD — | 2200.33 USD — | — - | — — |
| NASDAQ Biotechnology NBI | 4195.13 USD — |
-2.14
|
— — | 4174.1 USD — | 4266.29 USD — | — - | — — |
| NASDAQ HealthCare IXHC | 958.68 USD — |
-2.07
|
— — | 954.08 USD — | 972.42 USD — | — - | — — |
| Nasdaq US 700 Small Cap Index NQUS700SC | 2060.1 USD — |
-1.99
|
— — | 2051.95 USD — | 2093.4 USD — | — - | — — |
| Stlmt ID NASDAQ Biotechnology NBX | 4604.4 USD — |
-2.98
|
— — | 4555.41 USD — | 4917.8 USD — | — - | — — |
- {{ link.label }} {{link}}